ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription.
Activating Transcription Factor 3
/ genetics
Animals
Blood Vessels
/ pathology
Bone Marrow Transplantation
Cancer-Associated Fibroblasts
/ metabolism
Cell Proliferation
/ genetics
Chemokine CXCL12
/ genetics
Female
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Mice, Inbred C57BL
Mice, Knockout
Neoplasms, Experimental
/ genetics
Repressor Proteins
/ genetics
Tumor Microenvironment
/ genetics
Xenograft Model Antitumor Assays
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
13
09
2018
accepted:
03
01
2019
revised:
06
12
2018
pubmed:
24
1
2019
medline:
4
12
2019
entrez:
24
1
2019
Statut:
ppublish
Résumé
The activating transcription factor 3 (ATF3) and the c-Jun dimerization protein 2 (JDP2) are members of the basic leucine zipper (bZIP) family of transcription factors. These proteins share a high degree of homology and both can activate or repress transcription. Deficiency of either one of them in the non-cancer host cells was shown to reduce metastases. As ATF3 and JDP2 compensate each other's function, we studied the double deficiency of ATF3 and JDP2 in the stromal tumor microenvironment. Here, we show that mice with ATF3 and JDP2 double deficiency (designated thereafter dKO) developed larger tumors with high vascular perfusion and increased cell proliferation rate compared to wild type (WT) mice. We further identify that the underlying mechanism involves tumor associated fibroblasts which secrete high levels of stromal cell-derived factor 1 (SDF-1) in dKO fibroblasts. SDF-1 depletion in dKO fibroblasts dampened tumor growth and blood vessel perfusion. Furthermore, ATF3 and JDP2 were found to regulate SDF-1 transcription and secretion in fibroblasts, a phenomenon that is potentiated in the presence of cancer cells. Collectively, our results suggest that ATF3 and JDP2 regulate the expression of essential tumor promoting factors expressed by fibroblasts within the tumor microenvironment, and thus restrain tumor growth.
Identifiants
pubmed: 30670778
doi: 10.1038/s41388-019-0692-y
pii: 10.1038/s41388-019-0692-y
pmc: PMC6756089
doi:
Substances chimiques
Activating Transcription Factor 3
0
Atf3 protein, mouse
0
Chemokine CXCL12
0
Cxcl12 protein, mouse
0
JDP2 protein, human
0
Repressor Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3812-3823Références
Mol Cell Biol. 2002 Aug;22(15):5451-66
pubmed: 12101239
Cell. 2005 May 6;121(3):335-48
pubmed: 15882617
Am J Physiol Cell Physiol. 2007 Mar;292(3):C987-95
pubmed: 16943240
Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
pubmed: 12516034
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
J Mol Biol. 2005 Apr 22;348(1):43-62
pubmed: 15808852
Mol Cell Biol. 1997 Jun;17(6):3094-102
pubmed: 9154808
Cell Stem Cell. 2007 Sep 13;1(3):313-23
pubmed: 18371365
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1142-53
pubmed: 22989952
Oncogene. 2008 Apr 3;27(15):2118-27
pubmed: 17952119
Hepatology. 2015 Jan;61(1):238-48
pubmed: 25131778
Cancer Cell. 2008 Sep 9;14(3):263-73
pubmed: 18772115
Nat Med. 2003 Jun;9(6):677-84
pubmed: 12778166
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7159-E7168
pubmed: 28784776
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
J Vis Exp. 2013 Jan 14;(71):e4425
pubmed: 23354290
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14
pubmed: 21041659
Int J Cardiol. 2017 Dec 15;249:357-363
pubmed: 28893429
Gene. 2016 Sep 30;590(2):193-200
pubmed: 27041241
Cancer Cell. 2004 Jul;6(1):17-32
pubmed: 15261139
Nat Rev Cancer. 2006 May;6(5):392-401
pubmed: 16572188
FEBS Lett. 2001 Oct 12;506(3):196-200
pubmed: 11602244
J Clin Oncol. 2005 Oct 1;23(28):7212-20
pubmed: 16192605
Oncogene. 2010 Nov 25;29(47):6245-56
pubmed: 20802531
Blood. 2009 Nov 5;114(19):4310-9
pubmed: 19717647
J Clin Invest. 2013 Jul;123(7):2893-906
pubmed: 23921126
Nat Rev Cancer. 2009 Apr;9(4):239-52
pubmed: 19279573
Nature. 2005 Dec 8;438(7069):820-7
pubmed: 16341007
Oncotarget. 2015 Nov 10;6(35):37737-49
pubmed: 26497998
FEBS Lett. 2001 Jan 26;489(1):34-41
pubmed: 11231009
Carcinogenesis. 2011 Dec;32(12):1749-57
pubmed: 21900211
Cell Death Differ. 2014 Feb;21(2):216-25
pubmed: 24185619
Mol Cell Biol. 1996 Mar;16(3):1157-68
pubmed: 8622660
Nucleic Acids Res. 2008 Jun;36(11):3608-19
pubmed: 18463134
Gene Expr. 2010;15(1):1-11
pubmed: 21061913
Mol Cell Biol. 2004 Jul;24(13):5721-32
pubmed: 15199129
PLoS One. 2009;4(4):e4992
pubmed: 19352430
J Biol Chem. 2006 Apr 14;281(15):10473-81
pubmed: 16469745
J Biol Chem. 2004 Feb 13;279(7):5708-15
pubmed: 14627710
Curr Protoc Cell Biol. 2016 Mar 01;70:19.18.1-19.18.12
pubmed: 26930555
Nat Rev Cancer. 2013 Dec;13(12):871-82
pubmed: 24263190
Cancer Res. 1986 Feb;46(2):467-73
pubmed: 2416426
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15
pubmed: 23114846
Mol Cancer. 2010 Mar 09;9:54
pubmed: 20214788
J Cell Physiol. 2001 Sep;188(3):352-8
pubmed: 11473362
Semin Cell Dev Biol. 2010 Feb;21(1):33-9
pubmed: 19896548
Cancer Res. 2006 Apr 1;66(7):3639-48
pubmed: 16585189